Covid-19 Update Debate
Full Debate: Read Full DebateTim Farron
Main Page: Tim Farron (Liberal Democrat - Westmorland and Lonsdale)Department Debates - View all Tim Farron's debates with the Department of Health and Social Care
(2 years, 9 months ago)
Commons ChamberI can tell the hon. Gentleman that the antiviral drug that he refers to has been approved by the Medicines and Healthcare Products Regulatory Agency. We do have that drug, and since the point of approval last week we have already started deploying it in certain settings across the United Kingdom. We have put an order in for another antiviral, which has had very successful trial outcomes, but it has not received any final approval. If the MHRA independently decides to approve it—of course, that is a decision for the MHRA—the country will be in the fortunate position of having procured that drug, too.
One of the major objectives behind the successful vaccination programme is obviously to reduce infections, reduce hospitalisations and allow health professionals to focus on other, even more dangerous conditions, including cancer. The Secretary of State will be aware that in 2020, there were 35,000 missed cancer diagnoses. The London School of Economics study shows some 60,000 potential years of life being lost to cancer as a consequence of covid, and it is estimated that the NHS’s diagnostic and treatment services will have to work at 120% capacity for two solid years just to get back to March 2020 levels.
I suspect that the Secretary of State was as disappointed as I was that there was nothing in the Budget to help us to catch up with cancer. Will he follow the Government’s good example on the vaccine roll-out and adopt the same relentless focus on catching up with cancer, with targeted resources and leadership? Will he agree to meet clinicians and those involved in the cross-party Catch Up With Cancer campaign so we can work together to save those tens of thousands of lives, which will otherwise be unnecessarily lost?
The hon. Gentleman is absolutely right to raise the importance of cancer. For all the reasons he set out and more, it has remained an absolute priority of the Government and the NHS throughout the pandemic, despite the huge pressure that the NHS was under. Sadly, he is also right—I have spoken about this, just as he has—that many thousands of people went undiagnosed because they were asked to stay away from the NHS to protect it. We all understand why that happened, but sadly it had an unintended consequence. He is not right, though, to suggest that there was nothing in the Budget or the accompanying spending round to help with that problem. I draw his attention, for example, to the billions of investment in the new community diagnostic centres. There will be more than 100 across England, which will mean it will be much easier and quicker for GPs or others to refer people with suspected cancer for diagnosis. There are other examples, but I hope he is reassured that this remains an absolute priority.